Enterococci are bacteria that are normally present in the human intestines and in the female genital tract and are often found in the environment. These bacteria can sometimes cause infections. Vancomycin is an antibiotic that is often used to treat infections caused by enterococci. In some instances, enterococci have become resistant to this drug and thus are called Vancomycin-resistant enterococci (VRE).
Enterococci bacteria in the lower intestine and/or other areas (e.g., urine, blood, skin) may cause an infection and may be resistant to the antibiotic Vancomycin. Others may carry the bacteria without having symptoms. Risk factors for VRE acquisition include severity of underlying illness, presence of invasive devices, prior colonization with VRE, antibiotic use and length of hospital stay.
The spread of VRE occurs through contact. The bacteria can live on surfaces for days to weeks and on hands for several hours. The bacteria are relatively easy to kill with hospital grade disinfectants and good hand hygiene.
For more information on VRE, or to view VRE rates for other Ontario hospitals, please click on the link below.
Ministry of Health and Long-Term Care - VRE
SBGHC Quarterly Stat Report - VRE (2011-2012)
SBGHC Quarterly Stat Report - VRE (2010-2011)
SBGHC News| Next » Showing 1-1 of 83 entries. | |
|---|---|
Contract Awarded for Kincardine Site RedevelopmentCannon Design, an architectural design firm based in Toronto, has been awarded the contract for consultant/architectural services for the redevelopment of South Bruce Grey Health Centre’s (SBGHC) Kincardine site. Ten proposals were received in... |
|
| Next » | |
Board of Directors Meeting
Wednesday, February 22, 2012